Venus Remedies surges on reporting 28% rise in Q2 net profit

05 Nov 2012 Evaluate

Venus Remedies is currently trading at Rs. 311.70, up by 5.70 points or 1.86% from its previous closing of Rs. 306.00 on the BSE.

The scrip opened at Rs. 306.00 and has touched a high and low of Rs. 314.50 and Rs. 306.00 respectively. So far 24,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 316.00 on 25-Oct-2012 and a 52 week low of Rs. 141.05 on 22-Dec-2011.

Last one week high and low of the scrip stood at Rs. 314.50 and Rs. 290.60 respectively. The current market cap of the company is Rs. 303.00 crore.

The promoters holding in the company stood at 34.21%, while Institutions and Non-Institutions held 14.43% and 51.36% respectively.

The company has reported 28.42% rise in its net profit at Rs 15.09 crore for the quarter ended September 30, 2012 as compared to Rs 11.75 crore for the same quarter in the previous year.  Total income of the company has increased by 15.29% at Rs 110.81 crore for quarter under review as compared to Rs 96.11 crore for the quarter ended September 30, 2011.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

374.15 19.00 (5.35%)
13-Jun-2024 10:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1500.95
Dr. Reddys Lab 6050.50
Cipla 1531.70
Zydus Lifesciences 1092.25
Lupin 1613.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.